Vero Cell F Protein Expression for Stable Virus Vector Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing non-proliferative human parainfluenza type 2 virus vectors are complicated by the need for inducible expression systems and adenovirus assistance, leading to unstable viral replication and decreased production capacity over cell passages due to cytotoxicity of membrane proteins.
Innovation Solution
Utilizing Vero cells that constitutively and stably express the F protein of human parainfluenza type 2 virus, allowing for non-inducible expression and stable production of F gene-deficient viral particles, which are then used to generate non-proliferative virus vectors.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If inducible expression systems and adenovirus assistance are used to produce non-proliferative human parainfluenza type 2 virus vectors, then the virus can be made non-proliferative and safe, but the production process becomes complicated and production capacity decreases over cell passages
Solution Approach 1:
The patent extracts the F gene from the viral genome to create a defective virus that cannot proliferate, while separately providing F protein through a complementary expression system. This separation allows the virus to maintain infectivity without proliferation capability, resolving the contradiction between safety and production complexity by eliminating the need for complex inducible systems.
Solution Approach 2:
The patent uses a complementary DNA expression system as an intermediary to provide the F protein function that is missing from the F gene-defective virus. This mediator allows the defective virus to produce infectious particles without requiring complex inducible expression systems or adenovirus assistance, thereby simplifying the production process while maintaining non-proliferative capability.
2Productivity
If membrane proteins are expressed to enable virus replication, then viral particles can be produced, but cytotoxicity increases and production ability is lost after about 5 passages
Solution Approach 1:
The patent changes the expression parameters of the F protein by using a complementary DNA expression system that provides controlled, non-toxic levels of F protein expression. This allows viral particle production to continue stably over multiple cell passages without the cytotoxicity that normally limits production to about 5 passages, thereby resolving the contradiction between productivity and stability.
3Productivity
If adenovirus is used to induce F gene expression, then virus production is enabled, but gene introducing efficacy becomes unstable and complicates medicament manufacturing control
Solution Approach 1:
The patent replaces the complex adenovirus-based inducible system with a simpler complementary DNA expression system that provides stable, consistent F protein expression. This substitution eliminates the variability in gene introducing efficacy associated with adenovirus while maintaining virus production capability, thereby improving manufacturing precision and control.
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The present invention discloses a cell system, as a host cell to be infected with an F gene-deficient virus, which can constitutively and stably express the F protein, and a method for producing an F gene-deficient virus by utilizing the cell. A non-proliferative human parainfluenza type 2 virus vector is produced by co-culturing an F gene-deficient human parainfluenza type 2 virus with a Vero cell having the F gene of human parainfluenza type 2 virus in such a manner that the F gene is non-inducibly expressed, and isolating viral particles from a culture supernatant.